MSB 2.51% 97.0¢ mesoblast limited

Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-190

  1. 291 Posts.
    lightbulb Created with Sketch. 61
    I reckon it's more likely overwhelming efficacy will be reached at 2nd interim read out.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.